Posts by
Ted Driscoll
The human genome evolved for us as Paleolithic cavemen, arming us to cope with leopards, communicable diseases, infections, parasites and starvation. But modern society has succeeded in taming most of those risks, and now, ironically, our biggest health challenges are largely a byproduct of our success. As we extend our lifespan, cancer and cardiac disease increase in incidence. We confront an epidemic of diabetes and obesity related diseases largely caused by overconsumption and inactivity. Our genome never evolved to benefit obese 70 year olds. Cavemen didn’t typically live past 40 and didn’t drink high-fructose corn syrup in Big Gulps.
Read MoreCongratulations to Natera—our portfolio company who is the leading innovator in prenatal genetic testing! Yesterday they announced a major deal with Quest Diagnostics (NYSE: DGX), the world’s leading diagnostic information services company. Quest Diagnostics will offer physicians access to Panorama™, the new non-invasive prenatal test developed by Natera. (Read the Quest Press Release) Panorama uses […]
Read MoreA version of this article was originally published February 21, 2011 in The Health Care Blog Follow comments on the original blog post mHealth – otherwise known as mobile healthcare – sounds like just what the doctor ordered to help make healthcare delivery cheaper and more effective. And since the Internet today essentially resides in […]
Read MoreWhen I was in high school back in the 70’s, I remember my favorite physics teacher telling me about the difference between data and information. Data was raw, unprocessed and unlinked to any meaning. Information was what data became when it was linked to meaning. This was an important distinction that has even greater meaning […]
Read MoreI was at an event with a group of MBA students a couple of weeks ago, chatting with two of them. One asked me how the venture deal flow was different in the past. I made the off-hand comment that the World of Could seemed to have grown much bigger, but the World of Should […]
Read MoreLast year, Claremont Creek Ventures was exposed to over 500 startup ideas and entrepreneurs. As is probably typical in most early stage technology Venture Capitalists, we ultimately invest in less than 1% of the deals we see. That means we are saying “no” at least 99 times for every time we ultimately say “yes”. It […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.